Search results
4 days ago · Viral rashes are often associated with common childhood illnesses such as chickenpox, measles, fifth disease, and roseola. These rashes are typically characterized by red spots or bumps that may appear all over the body. They are usually accompanied by other symptoms of the underlying viral infection, such as fever, cough, or runny nose.
4 days ago · Close contacts should be monitored for signs and symptoms of illness for 10 days after the last known exposure to a patient with probable or confirmed HPAI A(H5N1) virus infection. Oseltamivir is recommended for post-exposure prophylaxis (at treatment dosing frequency of twice daily x 5 days) for certain people with HPAI A(H5N1) virus exposure.
5 days ago · Efficacy of Doxycycline as PEP to Prevent Bacterial STIs. Doxycycline Individual Level Harms – Antimicrobial Resistance. Doxycycline Use and Adverse Events. Sources. Provides tables of evidence in the use of Doxycycline Post-Exposure Prophylaxis for bacterial STI prevention.
15 hours ago · If a child shows symptoms of strep throat more than once in a span of a few days, this may be too concerning for many parents. A recurrent throat infection wouldn’t likely indicate an underlying problem, notwithstanding the child’s immune system. There are a few reasons why your child shows recurring symptoms despite treatment.
5 days ago · In the past 5 years, studies have examined the potential of doxycycline as post-exposure prophylaxis (PEP) for STIs. Doxycycline is a broad-spectrum tetracycline, recommended as treatment for chlamydia and syphilis and is not recommended for gonorrhoea due to high levels of resistance.
4 days ago · Postexposure prophylaxis can prevent symptomatic infection in asymptomatic household contacts if administered within 21 days of onset of cough in the index patient. Symptomatic, coughing household members of an index patient should be presumed to have pertussis.
1 day ago · HIV prevention measures include promoting condom use, providing pre-exposure prophylaxis (PrEP) to high-risk persons, and guaranteeing early HIV diagnosis and treatment. Harm reduction techniques, such as giving injectable drug users clean needles and syringes, can help limit the spread of HIV, hepatitis B virus (HBV), and hepatitis C virus.
